A meta-analysis sought to determine if survival is improved with dual targeting of the MAPK pathway with BRAF and MEK inhibitors vs BRAF inhibition alone in patients with advanced melanoma.
The Food and Drug Administration (FDA) has granted accelerated approval to Rozlytrek (entrectinib; Genentech)
Researchers examined whether adhering to the Mediterranean diet reduces the risk of skin cancer. We review their findings.
Cutaneous SCC risk reduced for highest versus lowest quintile of vitamin A, retinol, some carotenoids.
Patients are now able to get immunotherapies and targeted therapies at their local clinics, rather than having to travel to academic medical centers.